Metabolic effects of berberine on liver phosphatidate phosphohydrolase in rats fed on high lipogenic diet: An additional mechanism for the hypolipidemic effects of berberine

Asian Pacific Journal of Tropical Biomedicine

Volumn 4, Issue , 2014, Pages S429-S435

  Heidarian, Esfandiar ^a   Rafieian Kopaei, Mahmoud ^a   Khoshdel, Abolfazle ^a   Bakhshesh, Morteza ^b  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atherogenic index; Fatty liver; Flavonoid; Lipid profile; Lipogenic diet; Oxidative stress

Indexed keywords

ALCOHOL; BERBERINE; CHOLESTEROL; GEMFIBROZIL; LIPID; MALONALDEHYDE; PHOSPHATIDATE PHOSPHATASE; SUNFLOWER OIL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; HYPERLIPIDEMIA; HYPOLIPIDEMIC EFFECT; LIPID BLOOD LEVEL; LIPID DIET; LIPID LIVER LEVEL; MALE; METABOLISM; NONHUMAN; RANDOMIZATION; RAT;

HELIANTHUS; RATTUS;

EID: 84906685650     PISSN: 22211691     EISSN: None     Source Type: Journal    
DOI: 10.12980/APJTB.4.2014C474     Document Type: Article

References (31)

1. Ji HF, Shen L. Berberine: a potential multipotent natural product to combat Alzheimer's disease. Molecules 2011; 16(8): 6732-6740.
2. Carman GM, Han GS. Roles of phosphatidate phosphatase enzymes in lipid metabolism. Trends Biochem Sci 2006; 31(12): 694-699.
3. Heidarian E, Haghighi B. Enzymological characteristic of plasma membrane phosphatidate phosphohydrolase (PAP2) from rat liver. Iran J Sci Technol Trans A Sci 2008; 32: 117-127.
4. Klop B, Elte JWF, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients 2013; 5(4): 1218-1240.
5. Heidarian E, Soofiniya Y. Hypolipidemic and hypoglycemic effects of aerial part of Cynara scolymus in streptozotocininduced diabetic rats. J Med Plant Res 2011; 5(13): 2717-2723.
6. Johnson AM, Olefsky JM. The origins and drivers of insulin resistance. Cell 2013; 152(4): 673-684.
7. Saito I. Epidemiological evidence of type 2 diabetes mellitus, metabolic syndrome, and cardiovascular disease in Japan. Circ J 2012; 76(5): 1066-1073.
8. Ling H, Burns TL, Hilleman DE. Novel strategies for managing dyslipidemia: treatment beyond statins. Postgrad Med 2012; 124(6): 43-54.
9. Kim WS, Lee YS, Cha SH, Jeong HW, Choe SS, Lee MR, et al. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity. Am J Physiol Endocrinol Metab 2009; 296(4): E812-E819.
10. Derosa G, Maffioli P, Cicero AF. Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials. Expert Opin Biol Ther 2012; 12(8): 1113-1124.
11. Zhang Q, Xiao X, Feng K, Wang T, Li W, Yuan T, et al. Berberine moderates glucose and lipid metabolism through multipathway mechanism. Evid Based Complement Alternat Med 2011; doi: 10.1155/2011/924851.
12. Yin J, Ye J, Jia W. Effects and mechanisms of berberine in diabetes treatment. Acta Pharm Sin B 2012; 2(4): 327-334.
13. Heidarian E, Jafari-Dehkordi E, Seidkhani-Nahal A. Effect of garlic on liver phosphatidate phosphohydrolase and plasma lipid levels in hyperlipidemic rats. Food Chem Toxicol 2011; 49(5): 1110-1114.
14. Umeda Y, Kako Y, Mizutani K, Iikura Y, Kawamura M, Seishima M, et al. Inhibitory action of gemfibrozil on cholesterol absorption in rat intestine. J Lipid Res 2001; 42(8): 1214-1219.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18(6): 499-502.
16. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226(1): 497-509.
17. Yanagita T, Han SY, Wang YM, Tsuruta Y, Anno T. Cycloalliin, a cyclic sulfur imino acid, reduces serum triacylglycerol in rats. Nutrition 2003; 19(2): 140-143.
18. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
19. Agarwal R, Chase SD. Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 775(1): 121-126.
20. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 1996; 239(1): 70-76.
21. Bancroft JD, Gamble M. Microorganisms. In: Bartlett JH, editor. Theory and practice of histological techniques. 5th ed. Philadelphia, USA: Churchill Livingstone Elsevier; 2002, p. 325-344.
22. Yadav R, France M, Younis N, Hama S, Ammori BJ, Kwok S, et al. Extended-release niacin with laropiprant: a review on efficacy, clinical effectiveness and safety. Expert Opin Pharmacother 2012; 13(9): 1345-1362.
23. Porez G, Prawitt J, Gross B, Staels B. Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease. J Lipid Res 2012; 53(9): 1723-1737.
24. Andersen C, Rayalam S, Della-Fera MA, Baile CA. Phytochemicals and adipogenesis. Biofactors 2010; 36(6): 415-422.
25. Heidarian E, Jafari-Dehkordi E, Seidkhani-Nahal A. Lipid-lowering effect of artichoke on liver phosphatidate phosphohydrolase and plasma lipids in hyperlipidemic rats. J Med Plant Res 2011; 5: 4918-4924.
26. Wang Q, Zhang M, Liang B, Shirwany N, Zhu Y, Zou MH. Activation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2. PLoS One 2011; 6(9): e25436.
27. Wang YX, Kong WJ, Li YH, Tang S, Li Z, Li YB, et al. Synthesis and structure-activity relationship of berberine analogues in LDLR up-regulation and AMPK activation. Bioorg Med Chem 2012; 20(22): 6552-6558.
28. van Herpen NA, Schrauwen-Hinderling VB. Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav 2008; 94(2): 231-241.
29. Elabbadi N, Day CP, Gamouh A, Zyad A, Yeaman SJ. Relationship between the inhibition of phosphatidic acid phosphohydrolase-1 by oleate and oleoyl-CoA ester and its apparent translocation. Biochimie 2005; 87(5): 437-443.
30. Ondrejovičová I, Muchová J, Mišlanová C, Nagyová Z, Duračková Z. Hypercholesterolemia, oxidative stress and gender dependence in children. Prague Med Rep 2010; 111(4): 300-312.
31. Daleprane JB, Abdalla DS. Emerging roles of propolis: antioxidant, cardioprotective, and antiangiogenic actions. Evid Based Complement Alternat Med 2013; doi: 10.1155/2013/175135.